Leaps by Bayer

Building successful AgTech requires more than breakthrough ideas. Long development timelines, rigorous field testing, and farmer partnerships shape the real path to market. Explore four consistent truths in the new Ag Playbook 2.0: ag-playbook.vercel.app

Big congratulations to eGenesis on this outstanding recognition from Fast Company. Being named to the 2026 Most Innovative Companies list, including #1 in Biotech and #34 overall, is a powerful acknowledgment of the team’s work!

Early cancer–detection blood tests are generating attention. And just as many questions. Jürgen Eckhardt’s latest op‑ed in @Forbes breaks down what these tests can and can’t tell us today, why the science is promising, and where caution is still essential: forbes.com/sites/juergene…

Two decades of AgTech evolution. From early experimentation to today's disciplined investment environment. Ag Playbook 2.0 shows how capital-market shifts have shaped the sector. Understanding these eras helps everyone make smarter decisions. Read more: ag-playbook.vercel.app

PJ Amini recently spoke with @AgFunder about the current state of agrifoodtech investing – from exits and IPO dynamics to AI-driven discovery & emerging genetic tools. Curious to explore PJ’s full perspective? Read the interview: agfundernews.com/leaps-by-bayer…

Congrats on portfolio company NuCicer's partnership with Stricks Ag to deploy over 10,000 acres of high-protein chickpeas in the 2026 growing season, combining NuCicer's predictive breeding platform with Stricks Ag’s production network. Read more: igrownews.com/nucicer-latest…

Researchers are advancing new ways to restore sight. Diseases like retinitis pigmentosa and dry AMD damage the retina’s light-sensing cells. Stem cell therapies, gene-based approaches, and implants are now advancing with early signs of improvement. 👉 forbes.com/sites/juergene…

Where does CRISPR go next? Nobel Laureate Jennifer Doudna on the next phase: scalable treatments, earlier intervention, and impact in agriculture. Read the full interview: LINK

Gene editing is evolving, from correcting individual mutations to reimagining rare disease treatment at scale. Hear how David Liu's breakthrough advances in base and prime editing, delivery, and manufacturing are reshaping genetic medicine. Read more: forbes.com/sites/juergene…

We appreciate the trust of the @ReCodeTx team and the opportunity to support their work from an early stage. Working alongside Shehnaaz Suliman, our focus has been on providing support, network and perspective as the team advances its mission.

📢 Leaps portco one.bio, the first and only scientific platform to restore biological signals systematically removed from the modern food system, announced the launch of its fiber discovery & formulation technology yesterday — featured in @AgFunder. Read here:

JPM 2026 offered a clear signal: momentum is returning to healthcare innovation. M&A is back, China's innovation accelerating, AI showing real proof, global markets changing, new modalities moving fast. Read Jürgen Eckhardt's take in @Forbes: forbes.com/sites/juergene…

2025 marked 10 years of Leaps by Bayer: built on bold ideas and focused investment driving breakthroughs across health and agriculture.

Ten years of Leaps by Bayer backing breakthrough science across health and agriculture. A decade of impact turning ideas into real-world progress. 🚀 leaps.bayer.com/annual-review.…

Excited to share Bayer’s strategic collaboration and licensing agreement with Soufflé Therapeutics, following our initial investment. Together they aim to advance cell-specific siRNA therapy for dilated cardiomyopathy. Read more: businesswire.com/news/home/2026…

Our #AnnualReview2025 is out! 65+ companies with $2.1B invested and 20+ new & follow-on investments. 🚀 Report highlights: portfolio milestones, interview w/ Jennifer Doudna, breakthrough study insights, 10-year anniversary reflection. Take a look! 👀 💬 tinyurl.com/2wmr6arv

10 years of Leaps by Bayer. $2.1B+ invested, 65+ portfolio companies. 20+ new and follow-on investments in 2025. From cell therapy to gene editing to sustainable agriculture – breakthrough science is accelerating. Here's to the next decade. 🚀✨

🥩 Can climate concerns change eating habits?70% of Brazilians are open to cultivated meat, second only to Nigeria (81%).🌱 67% say environmental benefits could sway their choices.Full snapshot report 👉 leaps.bayer.com/Snapshot_repor…

2025 brought forward notable advances across gene therapy, genome editing, oncology, and cardiovascular health.Read Jürgen Eckhardt’s @Forbes op-ed for five breakthroughs that stood out this year.forbes.com/sites/juergene…

Read through some of the most exciting medical breakthroughs of 2025. From base editing that saved baby KJ's life to gene therapy restoring hearing and new progress in cancer and neurodegeneration, it’s a clear sign of how fast the field is moving. More: forbes.com/sites/juergene…